Recombinant proteins that combine different functions required for cell targeting and intracellular delivery of DNA present an attractive approach for the development of nonviral gene delivery vectors. Here, we described a novel protein termed ATF-lys10 which facilitated cell-specific gene transfer via receptor-mediated endocytosis. ATF-lys10 was composed of the amino-terminal fragment of urokinase and ten lysines at the carboxyl terminus. Bacterially expressed ATF-lys10 protein existed in soluble form, and had antigenicity of human urokinase. Purified ATF-lys10 specifically bound to uPAR-expressing cells and formed protein-DNA complexes with plasmid pGL3-control. After neutralization of excess negative charge with poly-L-lysine, these complexes served as a specific gene delivery vector for uPAR-expressing cells. Lysosomotropic compounds, such as chloroquine, drastically increased the ATF-lys10 mediated gene delivery efficiency. Our results suggest that the recombinant protein ATF-lys10 with the properties of DNA binding and tumor cell targeting represents a promising method for gene transfer and expression in tumor cells.
Viral vectors are widely used in gene therapy due to their high efficiency of gene transfer. However, major disadvantages of viral vectors for gene transfer include the limitation of cell type specificity and the size of incorporated DNA, the potential risk of mutagenesis, induction of toxic or immunological reactions, and the reversion to replication competence. Nonviral delivery systems for gene transfer are being developed, including receptor-mediated gene transfer systems. Such vectors are usually prepared chemically by covalent linkage of functional components with properties of DNA binding and cell targeting. Cationic polymers, such as poly-L-lysine (PLL) [1] and polyethylenimine (PEI) [2] , are able to bind plasmid DNA and protect it from enzymatic degradation, while folic acid [3] , transferrin [4] , mannose [5] , galactose [6] , epidermal growth factor [7] and oligopeptide ligand [8] are used for cell targeting moieties.
In this study, we produced a recombinant protein A TF-lys10 for gene delivery, which is composed of aminoterminal fragment (ATF) of urokinase (uPA) for binding uPA receptor (uPAR) and ten lysines at the carboxyl terminus of ATF for condensing plasmids.
Materials and Methods

Plasmids construction
Primers used in plasmids construction were listed in Table 1 . The open reading frame of ATF was amplified from plasmid pZWE-ATF-PAI2CD [9] , using primer 1 and primer 2. This 425-bp fragment has EcoRI and StuI site at 5' and 3' respectively. The plasmid containing the ATF-lys10 sequence was produced by ligating the 425-bp EcoRI-StuI fragment with pET32-HA-K [10], forming pET32-ATF-lys10. Plasmid pET32-∆ATF-lys10 which encoded mutant ATF-lys10 without amino acids 1-67 of ATF, was generated by digestion of pET32-ATF-lys10 with NcoI and then ligation. The gene fragment encoding ATF was obtained from pET32-ATF-lys10 by PCR using primer 3 and primer 4. After digestion with EcoRI and HindIII, the fragment was inserted into plasmid pET-32a(+) (Novagen), resulting in plasmid pET32-ATF, which encodes ATF without 10 lysines at the carboxyl terminus.
cDNA encoding the full-length uPAR was generated by
Table1
Primers used in plasmids construction
The restriction sites were underlined.
PCR, using primer 5 and primer 6. After digestion with EcoRI and BglII, the PCR product was inserted into vector pcDNA3.1/myc-his(-)A (Invitrogen). The recombinant plasmid was named pcDNA3.1-uPAR.
Production of recombinant proteins
Plasmid pET32-ATF-lys10, pET32-ATF and pET32-∆ATF-lys10 were transformed into E. coli strain BL21 (DE3), respectively. A well isolated colony was inoculated into LB medium containing 100 µg/ml ampicillin, and cultured under vigorous shaking at 37 °C. Expression of hexahistidine-tagged ATF-lys10, ATF and ∆ATF-lys10 were induced by adding IPTG (isopropyl-β-D-thiogalactopyranoside) to a final concentration of 1 mM, and cultured for additional 3 h. Bacterial cells were harvested by centrifugation at 6000 r/min for 15 min at 4 °C. Cells were resuspended in binding buffer (0.02 M Tris-HCl, 0.5 M NaCl, 5 mM imidazole) containing 1 mM protease inhibitor PMSF, followed by sonication at 800 W with 2 second-cycles of alternate sonication and resting. Cell extracts were clarified by centrifugation for 40 min at 10,000 r/min and 4 °C. Supernatant was filtered with a 0.45 µm filter and submitted to affinity chromatography on a histidine-binding resin column. Unbound proteins were removed with the binding buffer, and recombinant proteins were eluted with the imidazole buffer. 10 mM DTT was added to the elution fractions, and the solution was placed at 4 °C for 2 days. After that, 1 mM GSSG was added, and the mixture was placed for another 2 days at 4 °C, and then was dialyzed against 0.01 M phosphate buffer containing 0.01 M NaCl, and stored at -70 °C.
Western blot analysis
Purified recombinant proteins were separated under reducing conditions by 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membrane. The membrane was probed with polyclonal anti-human uPA antibody, followed by goat anti-mouse IgG. The band was visualized by incubation with DAB and H 2 O 2 in 1×PBS.
Gel retardation experiment [11]
Plasmid pGL3-control was incubated with 20 µg of ATF-lys10, ∆ATF-lys10 and ATF, respectively, in buffer (pH 7.4) containing 20 mM HEPES, 150 mM NaCl at room temperature. After 30 min, the mixture was separated in 0.8% agarose gel.
Cell lines and transfection
Strain 95D and 95C cells with different metastatic potential [12] , isolated from human large-cell lung carcinoma cell line PLA-801, were provided by the Cell Culture Laboratory of Department of Pathology, Chinese PLA General Hospital, and cultured in RPMI 1640 medium containing 10% bovine calf serum, 100 u/ml penicillin and 50 µg/ml streptomycin at 37 °C in a humidified CO 2 incubator with 5% CO 2 . Plasmid pcDNA3.1-uPAR and pEGFP-C3 (Clontech) were transfected into 95C cells or 95D cells with Lipofectamine TM reagent (Invitrogen) according to the manufacturer's instructions. 48-72 h after transfection, cells were used for gene delivery or subjected to microscopical observations.
Binding of ATF-lys10 to uPAR
Binding of ATF-lys10 to uPAR was determined by fluorescence-activated cell sorter analysis using 95D cells as previously described [13, 14] . 4×10 6 trypsinized cells were treated for 3 min at room temperature with 50 mM glycine-HCl buffer, pH 3.0, containing 100 mM NaCl. The mixture was neutralized by the addition of 0.5 volume of 0.5 M HEPES, 100 mM NaCl, pH 7.4, and then washed three times with buffer A (phosphate-buffered saline containing 1 mg/ml bovine serum albumin). Cells were collected by centrifugation, and resuspended in 200 µl of buffer B (binding buffer, serum-free RPMI 1640 medium containing 20 mM HEPES and 1 mg/ml bovine serum albumin, pH 7.4) in the presence of 20 nM ATF-lys10, ATF, ∆ATF-lys10, pro-uPA or IgG, respectively. Unbound were cloned into pET32-HA-K or pET-32a(+), and the obtained expression plasmids were named pET32-ATF-lys10, pET32-ATF and pET32-∆ATF-lys10.
(B) ATF is the amino terminal fragment (aa 1-135) of uPA; In ATF-lys10, ten lysines were fused to the carboxyl terminus of ATF; ∆ATF-lys10 is a mutant of ATF-lys10 lacking aa 1-67 of ATF. All of the three recombinant proteins were fused to the carboxyl terminus of thioredoxin (trx)-tag and His 6 -tag.
proteins were discarded, and cells were washed three times with buffer A and then treated with 3 µl of polyclonal antibody against human uPA in 50 µl of buffer B for 40 min followed by goat anti-mouse IgG as a secondary antibody. Fluorescence of cells was analyzed with FACScan.
Gene delivery using ATF-lys10/plasmid/PLL complex Transfection was performed as described [15] . Gene delivery complexes were prepared by incubation of 10 µg of plasmid pGL3-control or pEGFP-C3 with ATF-lys10 in a buffer containing 50 mM HEPES, 150 mM NaCl, pH 7.5, for 60 min at room temperature. To facilitate condensation of the protein-DNA complex, poly-L-lysine HBr (Sigma) with a molecular weight range of 15-30 kD was slowly added to the complex at various final concentrations, and the mixture (total volume of 100 µl) was incubated for an additional 60 min. For transfection, 5×10 5 cells were acid-treated and washed with serum-free medium. 1 ml of RPMI 1640 medium containing the ATF-lys10/ plasmid/PLL complex, 20 mM HEPES, 150 mM NaCl and 1 mg/ml BSA with or without 100 µM chloroquine (Sigma) was added into each well. After 4 h incubation at 37 °C in humidified air with 5% CO 2 , the medium was removed and 2 ml of complete culture medium was added, and the cells were further incubated for 48 h. Various amounts of pro-uPA were added to the mixture to investigate its effect on gene transfer efficiency.
Luciferase assay
Luciferase assay was performed as described in the Technical Bulletin No. 281 of luciferase assay system from Promega. The culture medium was removed, and the cells were washed three times with 1×PBS and lysed with 500 µl passive lysis buffer for 15 min at room temperature. The lysates were cleared by centrifugation, and the protein content of each sample was determined by the Bicinchoninic Acid (BCA) assay. The luminescence of each sample was recorded three times by using a luminometer in triplicate. The luciferase activity was represented as the number of relative light units in 1 mg protein (RLU/mg protein).
Results
Design and production of ATF-lys10, ATF and
The recombinant expression plasmids [ Fig. 1(A) ] were transformed into E. coli strain BL21(DE3) respectively. After induction, there was a band of recombinant protein with the expected molecular weight, and most of the recombinant protein existed in soluble form. The recombinant proteins ATF-lys10, ATF and ∆ATF-lys10, shown schematically in Fig. 1(B) , were purified by one-step affinity chromatography purification. On the SDS-PAGE analysis, the purified proteins displayed one prominent band at the expected molecular mass respectively [ Fig. 2  (A) ]. Western blot analysis showed that the recombinant proteins had the antigenicity of human uPA [ Fig. 2(B) ].
Gel retardation experiment
Plasmid pGL3-control was incubated with ATF-lys10, ∆ATF-lys10 and ATF at room temperature respectively. After 30 min, the sample was run in 0.8% agarose gel. ATF-lys10 and ∆ATF-lys10 but not ATF could efficiently bind and retard plasmid pGL3-control (Fig. 3) .
Fig. 2 SDS-PAGE and Western blot analysis of recombinant proteins
(A) SDS-PAGE analysis of recombinant proteins. M, protein marker; 1, 2 and 3, total protein of supernatant after sonication of E. coli strain BL21(DE3) respectively transformed with pET32-∆ATF-lys10, pET32-ATF-lys10 and pET32-ATF; 4, 5 and 6, purified recombinant proteins ∆ATF-lys10, ATF-lys10 and ATF respectively. (B) Western blot analysis of purified recombinant proteins; M, protein marker; 1, ATF; 2, ∆ATF-lys10; 3, ATF-lys10; 4, human pro-uPA.
Fig. 3
Gel retardation experiment 0.2 µg plasmid pGL3-control was incubated with 20 µg of ATF-lys10, ∆ATF-lys10 and ATF at room temperature respectively. After 30 min, the mixture was run in 0.8% agarose gel. 1, 0.2 µg plasmid pGL3-control + 20 µg ATF-lys10; 2, 0.2 µg plasmid pGL3-control; 3, 0.2 µg plasmid pGL3-control + 20 µg ATF; 4, 0.2 µg plasmid pGL3-control + 20 µg ∆ATF-lys10. 
uPAR-specific binding of ATF-lys10
It was reported that ATF could bind with high affinity to uPAR [16] . The function of ATF moiety in ATF-lys10 was investigated by fluorescence-activated cell sorter analysis to test if ATF-lys10 could also bind uPAR. 95D cells were incubated with ATF-lys10, ∆ATF-lys10 and ATF respectively, and specifically bound proteins were detected with polyclonal antibody against human uPA followed by FITC-labeled goat anti-mouse IgG. The results were shown in Fig. 4 . Efficient bindings of ATF-lys10 and ATF to uPAR were observed, but not ∆ATF-lys10.
ATF-ly10 facilitates gene transfer into 95D cells
Plasmid pGL3-control was used to determine if ATFlys10 could mediate gene transfer. The results were shown in Fig. 5(A,B) . ATF-lys10 could mediate gene transfer, and the efficiency depended on the ratio of PLL/plasmid (W/W) and concentration of ATF-lys10. The transfection efficiency was very high when the ratio of PLL/plasmid was 12 [ Fig. 5(A) ], or at the final concentration of 5 nM ATF-lys10 [ Fig. 5(B) ]. With the increase of concentration of ATF-lys10, the transfection efficiency reduced [ Fig. 5  (B) ]. To investigate the transfection efficiency, 10 µg pEGFP-C3, 5 nM ATF-lys10 and 120 µg PLL were formed into complex as described in Methods. 95D cells cultured in six-well plates were treated with the gene delivery complex, and the results were shown in Fig. 5(C) . 
ATF-lys10 mediated gene delivery was uPARtargeting
Recombinant protein ∆ATF-lys10 and ATF were used to investigate if ATF-lys10 mediated gene delivery was uPAR targeting. The recombinant proteins were respectively assembled into gene delivery complex as described in "Materials and Methods". 95D cells were treated with the gene delivery complexes. We found that ATF-lys10 mediated gene delivery was more efficient than ATF and ∆ATF-lys10 [ Fig. 6(B) ], which was inhibited by pro-uPA in dose-dependent manner [ Fig. 6(A) , column 1-5], but not low molecular weight uPA (lmw-uPA) which lacked the binding domain to uPAR [ Fig. 6(A), column 6 ]. In the other hand, plasmid pGL3-control was transfected into 95D cells, 95C cells and 95C cells transfected with pcDNA3.1-uPAR. uPAR expression levels in the three group cells were detected by Western blot analysis 
Discussion
Human uPA has 411 amino acids in length and is secreted as a 55 kD glycosylated protein. The binding domain is ATF (amino acid 1-135) which binds with high affinity (K d =0.5 nM) to its receptor uPAR [16] . uPAR is overexpressed on a variety of tumors, including monocytic and myelogenous leukemia and cancers of the colon, breast, bladder, thyroid, liver, pleura, lung, pancreas, ovaries, head and neck [17] . Recently, it has been reported that ATF and ATF-toxin fusion protein can bind to uPAR with high affinity and be specifically internalized by uPAR-expressing cells [18] . So we produced a recombinant protein ATF-lys10 which was composed of ATF and ten lysines as a kind of nonviral vector for gene delivery. ATF-lys10 can bind to uPAR via ATF domain, and bind plasmid DNA via ten lysines.
ATF-lys10 was expressed in E. coli strain BL21(DE3) using the pET-32a(+) expression vector. This vector encodes a 109 aa thioredoxin (trx-tag) domain immediately upstream of His-tag sequence that allows easy purification. The biosynthesis of foreign protein is controlled by the T7lac promoter repressed by lacI, which is also carried in the vector. This sort of vector should be used only in bacterial strains containing a chromosomal copy of the gene for T7 RNA polymerase. In this study, induction by 1 mM IPTG resulted in the expression of recombinant proteins in soluble form. After one-step affinity chromatography purification, recombinant protein ATF-lys10 was obtained with high purity. The purified protein could bind plasmid DNA and bind uPAR. The ATF-lys10/PLL/plasmid complex could be internalized by 95D cells, resulting in luciferase gene expression, while ATF lacking ten lysines and ∆ATF-lys10 lacking amino acids 1-67 of ATF could not mediate gene delivery efficiently [ Fig. 6(B) ]. The gene delivery efficiency in 95C cells was less than that in uPAR overexpression cells [ Fig. 6(C) ]. These data suggest that ATF-lys10 can mediate gene delivery, and ATF-lys10 mediated gene delivery is uPAR targeting.
Recombinant proteins ATF and ∆ATF-lys10 were use as control to demonstrate that ATF domain and ten lysines in ATF-lys10 were indispensable for gene delivery. ATF could bind uPAR on cell surface [ Fig. 4(D) ], but could not mediate gene delivery efficiently because of lacking of ten lysines [ Fig. 6(B) ]. ∆ATF-lys10 could bind plasmid (Fig. 3) , but could not mediate gene delivery efficiently [ Fig. 6(B) ] because of lacking amino acids 1-67 in ATF which led to inability of ATF binding to uPAR [ Fig. 4(A) ]. These data indirectly suggest that ATF-lys10 mediated gene delivery is uPAR targeting.
Lysosomotropic compounds such as chloroquine increased the efficiency of receptor-mediated gene delivery. Chloroquine is a weak base known to raise the pH of acidic compartments of the endocytosis pathway. The unprotonated chloroquine can easily enter the lysosome. In the lysosome, the molecules become protonated as a result of the low pH which led to its accumulation. The accumulation caused the swelling of lysosomes and destabilization of their membranes [19] . This is why chloroquine can favor receptor mediated gene delivery. In this study, 100 µM chloroquine increased efficiency of gene delivery obviously. Hemagglutinin exists as a homotrimer of disulfide-bonded peptide chains HA1 and HA2. The highly conserved segment at the N-terminus of HA2 consists of approximately 20 amino acid residues. This hydrophobic segment is essential for membrane fusion and called "fusion peptide". It has been demonstrated [4, 20] that the fusion peptide can augment efficiency of receptor mediated gene transfer. In this study, recombinant protein HA20-lys10 [10] did not increase gene transfer efficiency (data not shown), probably due to thioredoxin fused at its N-terminus which influence the structure change of "fusion peptide" under acid condition in lysosome.
In the gene delivery system, PLL was added to package plasmid DNA and neutralize its excess negative charge. The existence of PLL led to a nonspecific binding of plasmid/ATF-lys10 complex to cell, which could be seen in [ Fig. 5(B), column 1] . In the presence of ATF-lys10, the gene transfer efficiency was improved obviously, but the expression of reporter gene could not be completely inhibited by pro-uPA [ Fig. 6(A) , column 5], this was probably in part because of the existence of PLL.
In summary, ATF-lys10 can mediate gene delivery but the efficiency is low. Our results demonstrated that ATF-lys10 with properties of DNA binding and cell targeting had the potential to be used as nonviral vector in gene transfer and expression.
